FMI opines the Tocotrienol market was valued at USD 392.91 million in 2025. Sales are expected to reach USD 428.25 million in 2026 and USD 658.72 million by 2036. Dietary Supplements end-use is poised to lead with approximately 36.5% share in 2026 and Alpha Tocotrienol is estimated to command the Type segment with approximately 41.2% share in 2026.